ReviewCureus2023

Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements.

Kathryn White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.